ATE441849T1 - Cholesterin imitierende pyrensonden - Google Patents

Cholesterin imitierende pyrensonden

Info

Publication number
ATE441849T1
ATE441849T1 AT06726135T AT06726135T ATE441849T1 AT E441849 T1 ATE441849 T1 AT E441849T1 AT 06726135 T AT06726135 T AT 06726135T AT 06726135 T AT06726135 T AT 06726135T AT E441849 T1 ATE441849 T1 AT E441849T1
Authority
AT
Austria
Prior art keywords
membranes
pyrene
biological membranes
intensity
measurement
Prior art date
Application number
AT06726135T
Other languages
English (en)
Inventor
Roux Christophe Le
Andre Lopez
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE441849T1 publication Critical patent/ATE441849T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Toys (AREA)
AT06726135T 2005-03-23 2006-03-23 Cholesterin imitierende pyrensonden ATE441849T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502884A FR2883565B1 (fr) 2005-03-23 2005-03-23 Sondes pyreniques mimant le cholesterol
PCT/FR2006/000641 WO2006100388A2 (fr) 2005-03-23 2006-03-23 Sondes pyreniques mimant le cholesterol

Publications (1)

Publication Number Publication Date
ATE441849T1 true ATE441849T1 (de) 2009-09-15

Family

ID=35457953

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06726135T ATE441849T1 (de) 2005-03-23 2006-03-23 Cholesterin imitierende pyrensonden

Country Status (6)

Country Link
US (1) US8211881B2 (de)
EP (1) EP1861695B1 (de)
AT (1) ATE441849T1 (de)
DE (1) DE602006008903D1 (de)
FR (1) FR2883565B1 (de)
WO (1) WO2006100388A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5914500B2 (ja) 2011-09-12 2016-05-11 新日鉄住金化学株式会社 有機電界発光素子
CN104232077B (zh) * 2014-08-28 2016-06-15 陕西师范大学 基于胆固醇修饰的单芘荧光探针及其合成方法和应用
CN106047339B (zh) * 2016-06-23 2018-10-16 陕西师范大学 基于胆酸修饰的两亲性芘衍生物荧光探针及其合成方法和应用

Also Published As

Publication number Publication date
US8211881B2 (en) 2012-07-03
DE602006008903D1 (de) 2009-10-15
US20080187947A1 (en) 2008-08-07
WO2006100388A3 (fr) 2007-01-25
FR2883565B1 (fr) 2007-05-25
EP1861695A2 (de) 2007-12-05
WO2006100388A2 (fr) 2006-09-28
EP1861695B1 (de) 2009-09-02
FR2883565A1 (fr) 2006-09-29

Similar Documents

Publication Publication Date Title
Glasgow et al. Memantine and ketamine differentially alter NMDA receptor desensitization
Lückhoff et al. Increased free calcium in endothelial cells under stimulation with adenine nucleotides
Fujita et al. Intracellular alkalization causes pain sensation through activation of TRPA1 in mice
Atkinson et al. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter
Park et al. Molecular mechanism for local anesthetic action of eugenol in the rat trigeminal system
Yao et al. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP
Sakashita et al. Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats
ES2525251T3 (es) Dabigatrán liofilizado
Wilkes et al. Characterization of endothelin 1 receptor and signal transduction mechanisms in rat medullary interstitial cells
JP2013511549A (ja) ヘッジホッグ関連癌の治療のための方法及び組成物
Bréchard et al. Interleukin-8 primes oxidative burst in neutrophil-like HL-60 through changes in cytosolic calcium
Kiskin et al. Cross‐desensitization reveals pharmacological specificity of excitatory amino acid receptors in isolated hippocampal neurons
Chávez et al. Quantitative intracellular pH determinations in single live mammalian spermatozoa using the ratiometric dye SNARF-5F
Bozzo et al. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl) benzoylamino] benzyloxy] aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate
ATE441849T1 (de) Cholesterin imitierende pyrensonden
WO2017004516A1 (en) Device and method for analysis of tissue constructs
Criswell et al. Macrokinetic analysis of blockade of NMDA-gated currents by substituted alcohols, alkanes and ethers
Ursarescu et al. The assessment of Il-6 and RANKL in the association between chronic periodontitis and osteoporosis
Takeda et al. AVP-induced Ca fluxes and contraction of rat glomerular mesangial cells
Kornfeld et al. Cell calcium concentration in glomerular afferent and efferent arterioles under the action of noradrenaline and angiotensin II
Qhobosheane et al. A two-dimensional imaging biosensor to monitor enhanced brain glutamate release stimulated by nicotine
Yamada et al. Dopamine autoreceptors in rat nucleus accumbens modulate prepulse inhibition of acoustic startle
Watanabe et al. Xenon suppresses nociceptive reflex in newborn rat spinal cord in vitro; comparison with nitrous oxide
Oshiro et al. Protease-activated receptor-2-mediated Ca2+ signaling in guinea pig tracheal epithelial cells
Moelleken et al. An adverse wound environment activates leukocytes prematurely

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties